Kullmer T, Kindermann W
Eur J Appl Physiol Occup Physiol. 1985;54(4):350-4. doi: 10.1007/BF02337177.
Various publications have described a beta 2-receptor regulated potassium transport system in the cellular membrane of human skeletal muscle. To examine the suggestion that serum potassium alterations are among the causes of premature muscular fatigue during physical exercise under pharmacological blockade of beta-receptors, we have compared the influence of sustained blockade with a beta 1-selective blocker and a nonselective beta-blocker on the levels of serum potassium before, during and after a physical exercise test. 63 healthy physical education students received in random order and under double blind conditions either 100 mg Metoprolol (beta 1-selective) or 80 mg Propranolol (non-selective), or placebo daily for 3 months. Serum potassium was measured before, during (at 150 Watt and at the end of exercise) and after a bicycle exercise with a stepwise increase in work loads. After three months of beta-blocker treatment serum potassium levels during exercise were significantly higher than in control subjects receiving the placebo, and it took longer for the serum potassium levels to return to the resting level in the beta-blocker treated subjects. At rest, however, the levels were not found to be statistically different. In the subjects receiving Propranolol the post-exercise serum potassium levels were higher than in the subjects receiving Metoprolol. Three days after cessation of the medication these differences were no longer perceptible. Our findings confirm the existence of a beta-receptor regulated potassium transport system in human skeletal muscle and indicate that the transmembranous potassium transport in human skeletal muscle is predominantly regulated via beta 2-receptors, although beta 1-receptors seem also to be involved.(ABSTRACT TRUNCATED AT 250 WORDS)
各种出版物都描述了人类骨骼肌细胞膜中一种受β2受体调节的钾转运系统。为了检验在β受体的药物阻断作用下,血清钾变化是体育锻炼期间肌肉过早疲劳的原因之一这一观点,我们比较了β1选择性阻滞剂和非选择性β阻滞剂持续阻断对体育锻炼测试前、中、后血清钾水平的影响。63名健康的体育专业学生在随机顺序和双盲条件下,每天分别服用100毫克美托洛尔(β1选择性)或80毫克普萘洛尔(非选择性),或安慰剂,持续3个月。在进行工作量逐步增加的自行车运动前、运动期间(150瓦时和运动结束时)以及运动后测量血清钾。经过三个月的β阻滞剂治疗,运动期间的血清钾水平显著高于接受安慰剂的对照组,并且β阻滞剂治疗组的血清钾水平恢复到静息水平所需的时间更长。然而,在静息状态下,未发现这些水平有统计学差异。在接受普萘洛尔的受试者中运动后血清钾水平高于接受美托洛尔的受试者。停药三天后,这些差异不再明显。我们的研究结果证实了人类骨骼肌中存在受β受体调节的钾转运系统,并表明人类骨骼肌中的跨膜钾转运主要通过β2受体调节,尽管β1受体似乎也参与其中。(摘要截短至250字)